R

RaySearch Laboratories
RAY B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SEK11.47B
EV
SEK11.41B
Shares Outstanding
34.28M
Beta
1.11

Wall Street View

Analyst Rating
BUY
Analyst Target Price
SEK335.00
P/E 2025E
49.41x
P/Revenue 2025E
8.17x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About RaySearch Laboratories AB (publ)

gainify

R

RaySearch Laboratories AB (publ)

RAY B

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntellige...

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

Lof, Johan

Employees

422

IPO Date

2000-01-03

Headquarters

Eugeniavägen 18 C, Stockholm, Stockholm County, 113 68, Sweden

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.